“…Clinical hypnotherapy is alive and well, as Lynn et al (2000), Barabasz & Perez (2007), Mende (2009), Brann, Owens & Williamson (2012), Heap (2012 and Lynn et al (2012) have all demonstrated, even if, as Heap (2011Heap ( , 2012Heap ( , 2013 has suggested, the clinical application of hypnosis has continued doggedly to follow the historical traditions of Erickson and Hartland, In addition to weight loss, other, physiological benefits, may accrue from this hypnosis approach such as improvements in lipid and glucose metabolism, reducing medication needs for type-1 and type-2 diabetics (Xu & Cardeña, 2007), and the modulation of appetite and satiation associated peptides and hormones levels (Dimsdale & Herd, 1982). Such changes may arise indirectly from the reduction in body weight and adipose tissue, but may also be generated more directly through psychoneuroimmuno-and psychoneuroendocrinemechanisms in ways implied in publications by Hildebrandt et al (2000), Barber (2008), Hall, Stanton & Schultheiss (2010, Messina et al (2011), Pence et al (2012), and Fang et al (2012. Independently of any such physical and biochemical parameters of response to hypnosis (or even to non-hypnosis behavioural) mediated changes, are the emotional and psychological benefits that have been reported, even in the absence of substantial formal weight loss (Jupp et al, 1983;Friedman et al, 2002;Prag, 2007;Appleton, 2012;Wright et al, 2012).…”